Cargando…

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review

Background: Hepatocellular carcinoma (HCC) is a highly malignant cancer which lack of effective diagnosis and prognosis biomarkers, therefore surging studies focused on the metabolite candidates for HCC. The current study was designed to systematically review the metabolic studies for HCC, summarize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Ningning, Yu, Fatao, Yu, Feng, Feng, Yuling, Zhu, Xiaolin, Xie, Zhihui, Zhai, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772637/ https://www.ncbi.nlm.nih.gov/pubmed/35060504 http://dx.doi.org/10.1097/MD.0000000000028510

Ejemplares similares

A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma
por: De, Ji, et al.
Publicado: (2016)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

Factors associated with nonadherence to surveillance for hepatocellular carcinoma among patients with hepatic C virus cirrhosis, 2000–2015
por: Chang, Shen-Shong, et al.
Publicado: (2022)

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Mu-xing, et al.
Publicado: (2015)

MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
por: Huang, Juanjun, et al.
Publicado: (2021)

Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline
por: Zhu, Chunxiao, et al.
Publicado: (2017)

Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience
por: Dong, Jian, et al.
Publicado: (2016)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis
por: Han, Jie, et al.
Publicado: (2020)

Survival prediction model for postoperative hepatocellular carcinoma patients
por: Ren, Zhihui, et al.
Publicado: (2017)

Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Tang, Chengwu, et al.
Publicado: (2016)

HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022)

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma
por: Tu, Jianfei, et al.
Publicado: (2016)

Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population
por: Li, Qing-Min, et al.
Publicado: (2017)

Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)

Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review
por: Wang, Rui, et al.
Publicado: (2020)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis
por: Han, Yi, et al.
Publicado: (2022)

Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature
por: Qu, Meng-Meng, et al.
Publicado: (2021)

Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening: A Validation Set From China
por: Jiang, Li, et al.
Publicado: (2015)

Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature
por: Wang, Jun-Ke, et al.
Publicado: (2017)

Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2021)

Primary Squamous Cell Carcinoma of Liver: Case Series and Review of Literatures
por: Zhang, Xu-Feng, et al.
Publicado: (2015)

Surgical treatment of a rare case of hepatocellular carcinoma with right atrial metastasis: A case report
por: Qiu, Wei, et al.
Publicado: (2020)

A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
por: Chang, Yue, et al.
Publicado: (2020)

Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis
por: Liu, Qiuli, et al.
Publicado: (2021)

Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?: A systematic review and meta-analysis
por: Zhang, Tao, et al.
Publicado: (2020)

Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis
por: Xuan, Dongchun, et al.
Publicado: (2021)

Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study
por: Zhu, Yun-Feng, et al.
Publicado: (2019)

Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report
por: Chen, Kuo-Hsin, et al.
Publicado: (2016)

Clinical efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
por: Du, Sihao, et al.
Publicado: (2023)

Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk: A Systematic Review And Meta-Analysis
por: Peng, Qiliu, et al.
Publicado: (2014)

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

Anterior approach combined with infrahepatic inferior vena cava clamping right hepatic resection for large hepatocellular carcinoma: A prospective randomized controlled trial
por: Zhou, Yan-Ming, et al.
Publicado: (2016)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

Stent insertion with high-intensity focused ultrasound ablation for distal biliary obstruction secondary to pancreatic carcinoma
por: Yang, Shu-Ying, et al.
Publicado: (2020)

Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma
por: Xie, Junhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmkujktf79v33hrvbbhb44316m